Finance

Lists
Why is GEVO down 3.27%?
Dive Deeper
GEVO:NASDAQ
Gevo Inc
$1.77
-3.27%
(-0.060) 1D
Nov 16, 9:35:36 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GEVO...
Open
$1.80
High
$1.82
Low
$1.74
Mkt. cap
437.88M
Avg. vol.
4.32M
Volume
228.37K
52-wk high
$2.97
52-wk low
$1.09
EPS
-$0.77
Beta
1.13
Shares outstanding
247.38M
No. of employees
151
Open
$1.80
High
$1.82
Low
$1.74
Mkt. cap
437.88M
Avg. vol.
4.32M
Volume
228.37K
52-wk high
$2.97
52-wk low
$1.09
EPS
-$0.77
Beta
1.13
Shares outstanding
247.38M
No. of employees
151
News stories
From web sources and news partners
Profile
Gevo, Inc. is an American renewable chemicals and advanced biofuels company headquartered in unincorporated Douglas County, Colorado, in the Denver-Aurora metropolitan area. Gevo operates in the sustainability sector, pursuing a business model based on the concept of the "circular economy". The company develops bio-based alternatives to petroleum-based products using a combination of biotechnology and classical chemistry. Gevo uses the GREET model from Argonne National Laboratory as a basis for its measure of sustainability, with the goal of producing high-protein animal feed, corn-oil products, and energy-dense liquid hydrocarbons. Gevo is focused on converting sustainably grown raw materials, specifically No. 2 dent corn, into high-value protein and isobutanol, a primary building block for renewable hydrocarbons, including sustainable aviation fuel, renewable gasoline, and renewable diesel. Gevo markets these fuels as directly integrable on a “drop-in” basis into existing fuel and chemical products. Wikipedia
About Gevo Inc
CEOPatrick R. Gruber
Employees151
Founded2005
HeadquartersEnglewood, Colorado, United States
SectorEnergy
Industry-
Websitegevo.com
Analyst ratings
Based on 3 analysts giving stock ratings to GEVO in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for GEVO in the last 3 months.
Highest
Current $1.77
$14.00 (+690.92%)
Average
$6.32 (+257.04%)
Lowest
$1.70 (-3.96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeff Grampp
Northland Securities
Buy
Maintained
$3.25
+83.6%
11/11/2026
Amit Dayal
H.C. Wainwright
Buy
Reiterated
$14.00
+690.9%
11/11/2026
Unknown Analyst
Jefferies
Hold
Initiated
$1.70
-4%
09/09/2026
Lloyd Byrne
Jefferies
Hold
Initiated
$1.70
-4%
09/09/2026
Manav Gupta
UBS
Hold
Maintained
$2.00
+13%
05/22/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
45.35M
42.95M
46.50M
82.95M
Cost of goods sold
26.65M
23.27M
22.32M
30.48M
Cost of revenue
26.65M
23.27M
22.32M
30.48M
Research and development expenses
1.29M
1.50M
440.00K
1.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.69M
16.22M
12.88M
13.71M
Operating expense
24.06M
24.57M
59.89M
22.28M
Total operating expenses
50.71M
47.85M
82.21M
52.75M
Operating income
-5.36M
-4.90M
-35.71M
30.20M
Other non operating income
-1.04M
-1.89M
446.00K
-32.00K
EBT including unusual items
-6.01M
-21.35M
-176.26M
25.07M
EBT excluding unusual items
-9.19M
-11.05M
-40.26M
25.07M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
39.78M
500.00K
Net income
-6.30M
-21.70M
-176.94M
22.71M
Net profit margin
-13.89%
-50.52%
-380.51%
27.38%
Earnings per share
-0.01
-0.03
-0.01
0.12
Interest and investment income
1.93M
913.00K
630.00K
449.00K
Interest expense
-4.71M
-5.17M
-5.63M
-5.55M
Net interest expenses
-2.78M
-4.26M
-5.00M
-5.10M
Depreciation and amortization charges
5.08M
6.86M
6.78M
6.92M
EBITDA
-276.00K
1.96M
-28.92M
37.12M
Gain or loss from assets sale
-3.09M
533.00K
-323.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps